What smart money is saying about Organon & Co
OGN
No fund has written a full thesis on Organon & Co in our archive, but 1 fund letter reports a position in it — most recently Brandes IP Core Plus Fixed Income Fund in June 2026.
Get an email when a fund buys, sells or pitches it
1
Reported positions
0
Bought
0
Sold
1
Letter
Position history
Every position in Organon & Co on record in the archive was reported in Q2 2026, across 1 fund letter, with no move described.
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q2 2026 | 1 | 0 | 0 | 0 |
Fund activity · 1 position
- June 2026
“Select holdings in corporate bonds added to returns during the quarter, led by holdings in technology (Sabre Global and Pitney Bowes Inc.), pharmaceuticals (Organon and Baxter International), and communications (Fibercop and Univision Communications).”
Organon & Co
Read the letters behind these Organon & Co positions
Every quote above comes from a fund letter in our archive. Get unlimited access to the letters themselves — and to Warren AI, which reads all of them for you.
View plans→Share this ledger